Filing Details
- Accession Number:
- 0001209191-12-008786
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-02-09 17:50:30
- Reporting Period:
- 2012-02-08
- Filing Date:
- 2012-02-09
- Accepted Time:
- 2012-02-09 17:50:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1461993 | Cempra Inc. | CEMP | Pharmaceutical Preparations (2834) | 262644445 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1189158 | Sherrill P Neff | C/O Quaker Bioventures Cira Centre, 2929 Arch Street Philadelphia PA 19104 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-02-08 | 1,189,805 | $6.00 | 3,262,154 | No | 4 | P | Indirect | by Quaker BioVentures II, L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | by Quaker BioVentures II, L.P. |
Footnotes
- These shares were purchased in the Issuer's initial public offering.
- The reportable securities are owned directly by Quaker BioVentures II, L.P. ("Quaker"). The shares held directly by Quaker are indirectly held by Quaker BioVentures Capital II, L.P. ("Quaker GP"), as general partner of Quaker, and by Quaker BioVentures Capital II, LLC ("Quaker LLC"), as general partner of Quaker GP. As a result of the control that Quaker GP exercises over Quaker, and the control that Quaker LLC exercises of Quaker GP, each of Quaker GP and Quaker LLC may be deemed to beneficially own these securities. P. Sherrill Neff is a director of the Issuer and a managing member of Quaker LLC. Mr. Neff disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein.